Novo Nordisk A/S 2024 SR
The report highlights Novo Nordisk's 2024 sustainability performance, focusing on patient access, climate action, circular economy, and workforce wellbeing. Key achievements include reaching 45.2 million patients with diabetes and obesity care and 8.4 million vulnerable patients. The company introduced new targets to reduce scope 3 emissions by 33% and plastic footprint per patient by 30% by 2033, aiming for net zero by 2045. Additionally, Novo Nordisk launched a nature roadmap and expanded its Cities for Better Health initiative. The workforce grew to over 77,000 employees, with a focus on diversity and achieving 42% female representation in senior leadership.
Company: Novo Nordisk A/S
Sector: Manufacturing
Country: Denmark
Year: 2024
Type: SR
Pages: 16
Back to company
Novo Nordisk A/S
Sustainability Essentials
The report highlights Novo Nordisk's 2024 sustainability performance, focusing on patient access, climate action, circular economy, and workforce wellbeing. Key achievements include reaching 45.2 million patients with diabetes and obesity care and 8.4 million vulnerable patients. The company introduced new targets to reduce scope 3 emissions by 33% and plastic footprint per patient by 30% by 2033, aiming for net zero by 2045. Additionally, Novo Nordisk launched a nature roadmap and expanded its Cities for Better Health initiative. The workforce grew to over 77,000 employees, with a focus on diversity and achieving 42% female representation in senior leadership.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Renewable Energy
Women in Management
Net Zero Target
Employees